Company / Operating Income per Share
Tarsus Pharmaceuticals, Inc. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.85
FY2025
5-year range
-$5.36 / -$0.59
FY2021-FY2025
Trend
+47.5%
vs FY2024
Sector context
#114 of 201
Health Care
What the data says
At $-1.85, Tarsus Pharmaceuticals, Inc.'s operating income per share ranks #114 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 7 years, ranging from $-5.36 in FY2023 to $-0.59 in FY2022.
Based on SEC 10-K filings.
-1.85 in FY2025.
Improved from $-5.36 to $-1.85 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#114 of 201 in Health CareTop 57% of 201This company -$1.85 Sector average -$28.56
▼
+93.5% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 47.5% year-over-year.
- Ranks #114 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.85 | +47.5% |
| FY2024 | -$3.52 | +34.3% |
| FY2023 | -$5.36 | -812.9% |
| FY2022 | -$0.59 | +1.8% |
| FY2021 | -$0.60 | +86.2% |
| FY2020 | -$4.35 | -139.1% |
| FY2019 | -$1.82 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026